These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2006-001814-34 Effects of hypothermia on the disposition of morphine, fentanyl, midazolam and propofol in intensive care unit patients 2010-09-24 due-trials
Not reported 2008-004106-13 An Open-Label, Randomized, Multicenter Phase II Trial Comparing the Depletion of Malignant Stem Cells with Dasatinib vs. Imatinib in Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemi... 2013-10-06 due-trials
Reported results 2010-022897-14 A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study. 2014-09-01 due-trials
Reported results 2011-002203-15 Metformin treatment of pregnant PCOS women and prevention of late miscarriages and preterm birth The PregMet 2 Study 2017-10-02 due-trials
Listed as ongoing, but also has a completion date 2011-005989-38 A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ALPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA 2019-05-19 bad-data
Reported results 2012-000248-91 Endoscopic block of the sphenopalatine ganglion with botulinum toxin in intractable cluster headache. Safety issues. 2014-09-09 due-trials
Ongoing 2013-001237-41 A Randomized Phase III Study Comparing Maintenance Pemetrexed Therapy After Induction Chemotherapy Versus Pemetrexed at Progression in Advanced Non-Small-Cell Lung Cancer Randomisert fase III studi... not-yet-due
Listed as ongoing, but also has a completion date 2013-002282-19 A randomised, open-label trial of a Multimodal Intervention (Exercise, Nutrition and Anti-inflammatory Medication) plus standard care versus standard care alone to prevent / attenuate cachexia in adva... 2022-06-01 bad-data
Reported results 2014-001852-43 Botulinum toxin type A block of the sphenopalatine ganglion in chronic migraine. Safety issues 2016-02-01 due-trials
Ongoing 2015-004377-33 Botulinum toxin type A Block for the sphenopalatine ganglion in chronic rhinosinusitis With nasal polyposis not-yet-due
Reported results 2016-004072-22 NTNU Intranasal Naloxone Trial Double blinded, double dummy, randomised controlled trial of intranasal naloxone for pre hospital use 2020-10-06 due-trials
Reported results 2016-004213-28 Botulinum toxin type A block of the otic ganglion in chronic cluster headache. Safety issues. 2019-05-31 due-trials
Other 2017-004572-62 A randomized phase II study comparing atezolizumab after concurrent chemo-radiotherapy with chemo-radiotherapy alone in limited disease small-cell lung cancer not-yet-due
Ongoing 2018-000148-24 Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: the ExPlas Study Trent plasma som behandling for tidlig Alzheimers sykdom not-yet-due
Other 2018-003148-21 BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headache not-yet-due
Reported results 2019-002692-34 A pilot study on safety, feasibility and insulin-promotion by intra-inguinal lymph node injections of glutamic acid decarboxylase (GAD) in patients with LADA type of diabetes. 2022-05-05 due-trials
Other 2021-001648-91 Randomized phase III trial investigating the survival benefit of adding thoracic radiotherapy to durvalumab (MEDI4736) immunotherapy plus chemotherapy in extensive stage small-cell lung cancer not-yet-due
Other 2021-006810-35 68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma not-yet-due